{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:34:01Z","timestamp":1793093641735,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.bmcl.2018.11.038","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:57:54Z","timestamp":1542675474000},"page":"276-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides"],"prefix":"10.1016","volume":"29","author":[{"given":"Anna N.","family":"Tevyashova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Bychkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Korolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena B.","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena P.","family":"Mirchink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya A.","family":"Osterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9ka","family":"Erdei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Sz\u00fccs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Batta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.11.038_b0005","article-title":"Molecular mechanisms of antibiotic resistance","volume":"42\u201351","author":"Blair","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmcl.2018.11.038_b0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.bmcl.2018.11.038_b0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ja.2012.27","article-title":"Thoughts and facts about antibiotics: Where we are now and where we are heading","volume":"65","author":"Berdy","year":"2012","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2018.11.038_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ja.2016.72","article-title":"Antibiotics in the clinical pipeline at the end of 2015","volume":"70","author":"Butler","year":"2017","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2018.11.038_b0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1070\/RCR4448","article-title":"Design of dual action antibiotics as an approach to search for new promising drugs","volume":"84","author":"Tevyashova","year":"2015","journal-title":"Russ Chem Rev"},{"key":"10.1016\/j.bmcl.2018.11.038_b0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1517\/17460441.2010.508069","article-title":"Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance","volume":"5","author":"Pokrovskaya","year":"2010","journal-title":"Expert Opin Drug Discovery"},{"key":"10.1016\/j.bmcl.2018.11.038_b0035","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2174\/1568026617666170130115957","article-title":"Synthesis, properties, and mechanism of action of new generation of polycyclic glycopeptide antibiotics","volume":"17","author":"Olsufyeva","year":"2017","journal-title":"Curr Topics Med Chem"},{"key":"10.1016\/j.bmcl.2018.11.038_b0040","first-page":"71","article-title":"Glycopeptide resistance in enterococci","volume":"3","author":"Mendez-Alvarez","year":"2000","journal-title":"Int Microbiol"},{"key":"10.1016\/j.bmcl.2018.11.038_b0045","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/CMR.13.4.686","article-title":"Vancomycin-resistant Enterococci","volume":"13","author":"Cetinkaya","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmcl.2018.11.038_b0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(13)61219-2","article-title":"First case of infection with vancomycin-resistant Staphylococcus aureus in Europe","volume":"382","author":"Melo-Cristino","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2018.11.038_b0055","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/BF01967563","article-title":"Structure, biochemistry and mechanism of action of glycopeptide antibiotics","volume":"8","author":"Reynolds","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bmcl.2018.11.038_b0060","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus","volume":"49","author":"Higgins","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.11.038_b0065","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1128\/AAC.00760-10","article-title":"Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant Enterococci to effect rapid bacterial killing","volume":"54","author":"Belley","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.11.038_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/TCRM.S46","article-title":"Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review","volume":"4","author":"Bennet","year":"2008","journal-title":"Ther Clin Risk Manage"},{"key":"10.1016\/j.bmcl.2018.11.038_b0075","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1039\/C1CS15125H","article-title":"Recent advances in the synthesis of new glycopeptides antibiotics","volume":"41","author":"Ashford","year":"2012","journal-title":"Chem Sci Rev"},{"key":"10.1016\/j.bmcl.2018.11.038_b0080","doi-asserted-by":"crossref","first-page":"12661","DOI":"10.1021\/bi801597b","article-title":"The vancomycin-nisin hybrid restores activity against vancomycin-resistant Enterococci","volume":"47","author":"Arnusch","year":"2008","journal-title":"Biochem"},{"key":"10.1016\/j.bmcl.2018.11.038_b0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4155\/fmc.13.16","article-title":"Synthesis and study of antibacterial activities of antibacterial glycopeptides antibiotics conjugated with benzoxaboroles","volume":"5","author":"Printsevskaya","year":"2013","journal-title":"Fut Med Chem"},{"key":"10.1016\/j.bmcl.2018.11.038_b0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ja.2008.79","article-title":"A multivalent approach to drug discovery for novel antibiotics","volume":"61","author":"Long","year":"2008","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2018.11.038_b0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ja.2008.80","article-title":"Exploring the positional attachment of glycopeptides\/\u03b2-lactame heterodimers","volume":"61","author":"Long","year":"2008","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2018.11.038_b0100","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1128\/AAC.00712-12","article-title":"TD-1792 versus vancomycin for treatment of complicated skin and skin structure infections","volume":"56","author":"Stryjewski","year":"2012","journal-title":"Antimirob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.11.038_b0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00003088-199325050-00003","article-title":"Azithromycin clinical pharmacokinetics","volume":"25","author":"Lalak","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bmcl.2018.11.038_b0110","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/AAC.34.6.1056","article-title":"In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection","volume":"34","author":"Gladue","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.11.038_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/AAC.00852-06","article-title":"Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen","volume":"51","author":"Liu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2018.11.038_b0120","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1086\/605572","article-title":"Vancomycin in combination with other antibiotics for the treatment of serious Methicillin-Resistant Staphylococcus aureus infections","volume":"49","author":"Deresinski","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2018.11.038_b0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a b-lactam\u2013based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic Pneumococcal pneumonia","volume":"36","author":"Mart\u0131nez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2018.11.038_b0130","unstructured":"Sztaricskai F, Pelyv\u00e1s-Ferenczik I. Chemistry of carbohydrate components. In: Glycopeptide Antibiotics, 1st ed. (Ed. Nagarajan R.). New York, NY, USA: Marcel Dekker; 1994."},{"key":"10.1016\/j.bmcl.2018.11.038_b0135","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.7164\/antibiotics.42.1790","article-title":"Eremomycin \u2013 new glycopeptide antibiotics. chemical properties and structure","volume":"42","author":"Gause","year":"1989","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2018.11.038_b0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2006.04.008","article-title":"Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry","volume":"71","author":"Preobrazhenskaya","year":"2006","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmcl.2018.11.038_b0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ja.2009.108","article-title":"Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4\u201d-O-carbamate derivatives","volume":"63","author":"Ma","year":"2010","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmcl.2018.11.038_b0150","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.bmcl.2009.01.092","article-title":"Synthesis and antibacterial activity of 4\u2033,11-di-O-arylalkylcarbamoyl azithromycin derivatives","volume":"19","author":"Ma","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.11.038_b0155","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1016\/j.ejmech.2011.08.001","article-title":"Novel C-4\u201d-modified azithromycin analogs with remarkably enhanced activity against erythromycin-resistant Streptococcus pneumonia: the synthesis and antimicrobial evaluation","volume":"46","author":"Ma","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2018.11.038_b0160","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1128\/AAC.05395-11","article-title":"Attenuation-based dual-fluorescent-protein reporter for screening translation inhibitors","volume":"56","author":"Osterman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.bmcl.2018.11.038_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174372","article-title":"Pharmacokinetics of a single 1g dose of azithromycin in rectal tissue in men","volume":"12","author":"Kong","year":"2017","journal-title":"PLoS One"},{"issue":"S1","key":"10.1016\/j.bmcl.2018.11.038_b0170","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18309053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18309053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:29:21Z","timestamp":1760772561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18309053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0960894X18309053"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.11.038","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.11.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}